Bond.az White LogoBond.az Black Logo

Truist Raises Target Price Target to $130

Truist Securities raises Target price target to $130 after strong Q1 results. Comparable sales up 5.6%, earnings beat estimates.

Sarah Johnson
BySarah Johnson- Senior Editor
|
0

Truist Securities raised its price target on Target Corp. (NYSE:TGT) to $130 from $123 while maintaining a Hold rating.

The retailer posted a strong quarter with comparable sales rising 5.6%. Benefits came from easy year-over-year comparisons, outsized tax refunds, and demand for Pokémon merchandise.

Truist credited Target's improvements in merchandising, new products, and customer experience. The valuation expanded to 14-15 times earnings. The stock trades at a P/E of 15.04, but Bond.az data suggests shares remain undervalued relative to Fair Value.

The analyst noted challenges ahead as first-quarter benefits fade. Target's multiple was compared to Home Depot and Lowe's, which trade at slightly higher multiples. Truist maintains Buy ratings on both.

In other news, Target reported Q1 2026 earnings beating estimates with adjusted EPS of $1.71 versus $1.46 expected. Revenue hit $25.4 billion vs. $24.66 billion forecast. However, rising SG&A expenses and lower operating margin raised concerns. Freedom Broker downgraded Target from Buy to Hold, lowering the price target to $130 from $145.

More News
Today / 18:50
|
613

Jefferies Raises Eagle Materials Price Target on Infrastructure Demand

Jefferies raised Eagle Materials price target to $200, citing infrastructure demand. Cement volumes strong from projects and data centers.

0
Today / 14:32
|
515

Benchmark Raises Snowflake Target to $200

Benchmark raises Snowflake price target to $200 ahead of earnings, citing strong growth and AI adoption. Stock appears undervalued according to Bond.az analysis.

0
Today / 14:32
|
794

Benchmark raises Payoneer price target to $9

Benchmark raises Payoneer price target to $9 on strong B2B growth and Q1 2026 results. See details and analysis.

0
Today / 13:31
|
519

William Blair Starts Insulet at Outperform

William Blair initiates Insulet at Outperform. Stock trades at 24x EPS, undervalued per Bond.az. Key concerns and catalysts detailed.

0
Today / 12:32
|
782

Deutsche Bank upgrades Centene stock on earnings recovery

Deutsche Bank upgrades Centene stock to Buy with a new price target of $80. Bond.az analysis highlights undervaluation. Latest news on Centene.

0
Today / 12:31
|
744

Deutsche Bank upgrades Elevance stock

Deutsche Bank upgraded Elevance Health to Buy with a $498 price target, citing stable managed care market. Strong Q1 results also boost confidence.

0
Today / 12:11
|
262

BMO Raises Israel Chemicals Target Price on Potash

BMO Capital raises Israel Chemicals price target to $6.50 on strong potash outlook and higher EBITDA guidance.

0
Today / 12:10
|
223

Cantor Fitzgerald raises PANW price target to $285

Cantor Fitzgerald raises Palo Alto Networks price target to $285, citing platformization, AI tailwinds, and strong partner results.

0
Today / 11:53
|
435

Stifel Maintains Manhattan Associates Price Target

Stifel maintains Buy rating and $200 target for Manhattan Associates. The company is investing in cloud migration and agentic AI capabilities.

0
Today / 11:52
|
256

Rosenblatt Raises 8x8 Target to $3.00

Rosenblatt raises 8x8 stock target to $3.00 after strong Q4 results. Revenue beat guidance.

0
Today / 11:52
|
385

Piper Sandler Reiterates Alphabet Overweight on AI

Piper Sandler reiterates Alphabet Overweight rating and $425 target after Google I/O AI product launches.

0
Today / 11:51
|
464

Rosenblatt Cuts Canaan Target Price to $1.30

Rosenblatt cuts Canaan stock price target to $1.30 from $2.25, maintains Buy rating. Canaan faces revenue miss in Q1 FY2026.

0
...